Survival trends: pancreatic cancer in the USA

survival trends: pancreatic cancer in the USA STUDY BACKGROUND  Pancreatic cancer (PC) is a devastating malignancy with a 5-year survival rate of 10%. Despite accounting for only 3% of all new cancer diagnoses, it is the third leading cause of cancer-related deaths in the US. Surgical resection is the only potentially curative

Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study

Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study Cases of complete remission of cancers with brain metastases are very rare. It’s often brought by tyrosine kinase inhibitor monotherapy in patients with metastatic renal cell carcinoma. For metastatic renal cell carcinoma (mRCC) patients, the case of brain metastasis has been

Living With Mesothelioma: Lifestyle Tips You Should Know About

Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. Living With Mesothelioma: Lifestyle Tips You Should Know About In 2020, an estimated 30,870 individuals were diagnosed with mesothelioma worldwide. In the United States, it affects around 3,000 individuals every

Colorectal Cancer Screening for Older Adults

Colorectal Cancer Screening for Older Adults Overview of the Study Colorectal cancer (CRC) is the second most deadly cancer worldwide. As such, the need for resilient colorectal cancer screening (CRCS) is increasingly becoming more important to reduce complications due to delays in care. However, the realistic participation target remains unelucidated.  This research aims

Ovarian adenocarcinoma with glaucoma: A case report

Ovarian adenocarcinoma with glaucoma: A case report Introduction Metastatic tumor accounts for the most common ocular malignancy in adults. In rare cases, ocular metastasis can represent the initial manifestation of an undiagnosed primary cancer such as breast and lung cancers. Patients usually present with visual field defects, ocular pain, floaters, photophobia, or

thyroid malignancy and serum calcitonin

thyroid malignancy and serum calcitonin Overview  Medullary thyroid cancer (MTC) is a rare type of thyroid cancer. It’s known to have poorer outcomes than differentiated thyroid cancer. In this article, the researchers aimed to identify areas for improvement in the preoperative evaluation of patients with possible MTC in a high-volume endocrine surgery

Survival trends: pancreatic cancer in the USA